A randomized placebo-controlled trial was designed to compare the efficacy of 26-week intervention, composed of either 2.2 g/day of n-3 PUFA, or olive oil placebo, with regard to symptom severity in first-episode schizophrenia patients. Seventy-one patients (aged 16-35) were enrolled in the study and randomly assigned to the study arms. The findings suggest that 6-month intervention with n-3 PUFA may be a valuable add-on therapy able to decrease the intensity of symptoms and improve the level of functioning in first-episode schizophrenia patients.
Service Hotline
+86 411 6586466
NO.49,DDA,Dalian,116600,P.R.Chin
Company News
A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsatu
Page view
Previous article:
无
无
Next article: